Presentations from the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer

 

 

SESSION I (PART 1): PATIENT POPULATION PRIOR TO DIAGNOSIS OF PROSTATE CANCER: SCREENING AND CLINICAL EVALUATION OF MEN WITH CLINICAL SUSPICION

Welcome and Opening Remarks

Faina Shtern, MD, presented opening remarks for 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer.

Year in Review: Emerging Data and Advances in Screening

Sigrid Carlsson, MD, PhD, MPH, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.

Update on PROBASE Trial: Baseline PSA in Young Men (Aged 45 and 50)

Peter Albers, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.

Update on the PROFILE and IMPACT Studies

Jana McHugh, MB, BCh, BAO, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.

Overview of MCED – Performance and Impact on Prostate Cancer

Erik A. Klein, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.

MRI-Based Prostate Cancer Screening in an Era of MCEDs

Mark Emberton, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.

Update on PRAISE-U Project – European Union Initiative in PC Screening

Monique Roobol, PhD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.

The BARCODE 1 Study: Enrichment of Prostate Cancer Detection in Those with Higher Polygenic Risk

Ros Eeles, PhD, FRCP, FRCR, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.

SESSION I (PART 2): PATIENT POPULATION PRIOR TO DIAGNOSIS OF PROSTATE CANCER: SCREENING AND CLINICAL EVALUATION OF MEN WITH CLINICAL SUSPICION

Overview of Liquid Biomarkers

E. David Crawford, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.

Optimization of Prostate Biopsy – Micro-Ultrasound versus MRI (OPTIMUM)

Laurence Klotz, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.

MRI PI-RADS Standardization and Clinical Evaluation

Clare Tempany, MB, BAO, BCh, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.

Bi-Parametric Optimized 15 min Protocol with Deep Learning Acceleration for Prostate MRI – Are we there yet?

Mukesh Harisinghani, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.

Optimizing MRI Techniques for Prostate Cancer Diagnosis

Fergus Coakley, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.

Update of Changes in the Early Detection of Prostate Cancer NCCN Guidelines 2024

Preston Sprenkle, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.

PANEL ON BIOINFORMATICS, ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING FOR A MULTI-MODALITY DATA ANALYSIS FOR PRECISION DIAGNOSIS AND TREATMENT

Leveraging Big Data in Surgery through HL7 Integration and Computer Vision

Archan Khandekar, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.

Results from the Norwegian Prostate Cancer Consortium (NPCC)

Jan Oldenburg, MD, PhD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.

Connected Care and Latest Developments in Prostate Cancer Management

Ilya Gipp, MD, PhD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.

SESSION II (PART 1). CLINICAL EVALUATION AND MANAGEMENT OF MEN WITH LOCALIZED AND RECURRENT PROSTATE CANCER

Genomics and Natural History of MRI Invisible vs Visible Cancers- Implications for Clinical Practice

Laurence Klotz, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

Utility of Micro-Ultrasound in Prostate Cancer Active Surveillance

Adam Kinnaird, MD, PhD, FRCSC, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

MRI in Localized and Recurrent Prostate Cancer

Baris Turkbey, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

Molecular Imaging and Prostate

Stefano Fanti, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

Criteria for the Development and Validation of Radiomic Tests in Diagnosis and Treatment of Prostate Cancer

Erich Huang, PhD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

Novel and Emerging Pathological Factors in Localized and Recurrent Prostate Cancer

Gladell P. Paner, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

Integration of MRI with Histology, Genomics, and Proteomics

Steven Raman, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

SESSION II (PART 2): CLINICAL EVALUATION AND MANAGEMENT OF MEN WITH LOCALIZED AND RECURRENT PROSTATE CANCER

Away from the Gleason Score and Towards Quantification of Pattern 4 for Treatment Decision Making in Localized Prostate Cancer

Andrew Vickers, PhD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

Artificial Intelligence for Improving Prostate Cancer Management

Wayne Brisbane, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

Current Status of External Validation of Inter-Reader Reproducibility for the Prostate Imaging Quality (PI-QUAL)

Liang Wang, MD, PhD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

Integrated Diagnostics for Risk Stratification and Active Surveillance

Sanoj Punnen, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

Emerging Role of Focal Therapy in the Management of Prostate Cancer

Bruno Nahar, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

Focal Brachytherapy for Prostate Cancer

Daniel Y. Song, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

SESSION III: POPULATION OF MEN WITH ADVANCED PROSTATE CANCER

Review of the New Standard in Treatment – Androgen Deprivation Treatment (ADT), Chemotherapy, Androgen Receptors Inhibitors, and Androgen Synthesis Inhibitors

Marc Garnick, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

Multi-Disciplinary Approach to Advanced Prostate Cancer Care

Kelvin A. Moses, MD, PhD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

Population of Men with Advanced Prostate Cancer: Sequencing of Treatment

Arnulf Stenzl, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

Radiation Therapy Planning Using Advanced Imaging – Pearls and Pitfalls

Sean P. Collins, MD, PhD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

Novel Targeted Therapies

Daniel P. Petrylak, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

Transforming Prostate Cancer Care – The Emerging Role of Radio-Ligand Therapies

Ilya Gipp, MD, PhD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

Immunotherapy in Prostate Cancer

Sandy Srinivas, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

Molecular Imaging for Staging and Treatment Planning, including Patient Eligibility and Selection for LuPSMA Therapy

Hong Song, MD, PhD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 9, 2024.

SESSION IV: PRECISION DIAGNOSTICS AND EMERGING ROLE OF IMAGE-TARGETED, MINIMALLY INVASIVE TREATMENT: Multimodality Diagnostics for Improved Target Definition, Patient Selection, Monitoring & Outcomes

Changing Relationship between Active Surveillance and Focal Therapy

Mark Emberton, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

Focal Therapy for Prostate Cancer – How to Choose an Optimal Weapon?

David Margel, MD, PhD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

Patient Selection for Focal Therapy – Radiologic Perspective

Jurgen Futterer, MD, PhD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

Focal Therapy Patient Selection: Role of Multiomics

John Feller, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

Focal Therapy Patient Selection: Urologist Perspective

Geoffrey Sonn, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

Focal Therapy Recurrences and their Management

Abhinav Sidana, MD, MPH, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

Prostate Cancer Ablation using MRI-Guided Transurethral Ultrasound (TULSA-PRO): How I Do It?

Ram A. Pathak, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

Post-Treatment Assessment and Creating Imaging-Based Short- and Intermediate-Term Patient Outcomes

Faina Shtern, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

Standardized MRI and Molecular Imaging Reporting for Focal Therapy Follow-up

Daniel Margolis, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

TARGET Consensus on Post-Treatment MRI Reporting

Taimur T. Shah, MBBS, BSc (Hons), FRCS, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

PI-FAB Standardization of MRI Reporting

Francesco Giganti, MD, PhD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

MRI After Focal Treatment

Sangeet Ghai, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

Molecular Imaging Post Focal Treatment Emerging Data

Stefano Fanti, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

A Pilot Study of 68Ga-PSMA11 and 68Ga-RM2 PET/MRI for Evaluation of Prostate Cancer Response to High-Intensity Focused Ultrasound Therapy

Heying Duan, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

PSMA PET for Focal Therapy

Irene Burger, MD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

PANEL ON PRECISION CARE AND HEALTH DISPARITIES IN PROSTATE CANCER

Prostate Cancer Risk Assessment in Black Men

Adam B Murphy, MD, MBA, MSCI, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

Utilization and Disparity in Prostate Cancer Risk Assessment Tools

Michael Leapman, MD, MHS, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

PROWESS: (PROstate Cancer Wearables, Exercise, and Structured Supports)

Jamie Jacobs, PhD, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

Empowering Communities: Fostering Prostate Cancer Awareness and Resilience Among Men of Color

Quoc-Dien Trinh, MD, MBA, presented this lecture during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 10, 2024.

PRESENTATION OF WINNING ABSTRACTS

PRESENTATION OF WINNING ABSTRACTS

First Place: Extracapsular Extension Risk Assessment and Localization Using an Artificial Intelligence Prostate, Sakina Mohammed Mota, PhD, Data Scientist, Avenda Health

Second Place (Tied)
Performance of an AI-assisted Whole Prostate Gland Segmentation Module for MRI-Guided Transurethral Ultrasound (TULSA) Treatment Planning – Multi-Reader Multi-Case Study: Steven Raman, MD, UCLA

Clinical, Pathological and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and mpMRI: Ida Sonni, MD, Project Scientist, UCLA

Third Place (Tied)
Artificial Intelligence Prostate Segmentation Integrated into Treatment Planning Software for MRI-Guided Transurethral Ultrasound Ablation – Initial Real-World Experience: Steven Raman, MD, UCLA

Diagnostic Performance of a Locally Developed Multiparametric MRI Scoring System for the Detection of Prostate Cancer After Focal Ablative Therapies in Prostate Cancer – Toronto Score: Sangeet Ghai, MD (Presented in Session IV)